Table 5.
Authors | Number of Studies Included | Type of Studies Included | Number of Participants and Gender/Age/Characteristics | Compound and Doses | Observed Effects |
---|---|---|---|---|---|
Meta-analysis | |||||
Chen et al., 2015 [86] | 15 | RCT | 30–252 perimenopausal or postmenopausal women/report (1753 in total) 49–58.3 years (placebo group) 48–60.1 years (phytoestrogen group) |
Isoflavones 5–100 mg/day Intervention period: 3–12 months |
Reduction of hot flush frequency (vs. placebo) |
Li et al., 2015 [87] | 16 | RCT | 24–236 women/report (median 90) 40–65 years |
Soy isoflavones 30–200 mg/day Intervention period: 4 weeks–2 years (median 12 weeks) |
Slight and slow attenuation of hot flushes (vs. estradiol) |
Li et al., 2016 [88] | 39 | RCT | 24–620 women/report (median 200) Age not available |
SSRIs/SNRIs: 7.5–200 mg/day Gabapentin: 300–1800 mg/day Clonidine: 0.1–0.4 mg/day Soy isoflavones: 30–200 mg/day Intervention period: 2–96 weeks (average 12 weeks) |
Slight and slow attenuation of hot flushes (vs. non-hormonal drugs) |
Daily et al., 2019 [85] | 5 | RCT | 728 menopausal women (total subjects) 50.5–58.8 years (mean) |
Soy isoflavones: 33–200 mg/day and 6 g soy extract/day Equol: 10 mg/day Intervention period: not available |
Equol or isoflavone in equol-producers more effective than placebo |
Sarri et al., 2017 [89] | 32 | RCT | 4165 menopausal women (total subjects) 45+ years |
Isoflavones and black cohosh (Doses not available) |
Reduction of VSM (hot flushes and night sweats) compared to placebo No beneficial effect (vs. pharmacological treatment) |
Franco et al., 2016 [90] | 17 | RCT | 30–252 women/trial 40–69 years |
Dietary soy isoflavones: 42–90 mg/day Supplements and extracts of soy isoflavones: 10–100 mg/day Red clover: 40–160 mg/day Intervention period: 12–48 weeks |
Reduction of hot flush frequency by means of dietary isoflavones and supplements) Reduction of night sweat frequency by red clover |
Systematic reviews | |||||
Chen et al., 2019 [86] | 15 | RCT (9) Prospective study (2) Systematic review (2) Randomized crossover trial (1) Meta-analysis (2) |
51–403 menopausal and postmenopausal women | Soy (soy nut, soy protein, soy extracts) Natural isoflavones Synthetic isoflavones |
Beneficial effects of isoflavones (vs. placebo) Synthetic or combination of isoflavones more effective than natural soy HRT more effective than soy or its extracts Isoflavone in equol-producers or equol supplementation more effective than placebo. |
Perna et al., 2016 [52] | 7 | RCT | 40–403 menopausal and postmenopausal women | Isoflavones 50–120 mg/day Intervention period: 8 weeks–2 years |
Reduction of hot flush frequency |
HRT: hormone replacement therapy, RCT: randomized controlled trial, VSM: vasomotor symptoms.